Advances in Heart Failure - Key Trials Impacting Management

In this presentation, Dr. Ajith Nair discusses clinical trials influencing the treatment of advanced heart failure.

This Department of Medicine Grand Rounds session took place on Thursday, January 14, 2021 at 12:15 P.M. and is approved for MOC credit.

CME Information

Needs Statement

Faculty and trainees within the Department of Medicine who are involved in the care of patients need to be regularly updated with the recent advances and guidelines in the fields of internal medicine and quality improvement to increase clinical knowledge, and to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.

Objectives

At the conclusion of this activity, the participant should be able to:

  • Summarize the role of SGLT-2 inhibitors in heart failure with reduced ejection fraction (HFrEF).
  • Appraise the role of angiotensin receptor neprilysin inhibitor (ARNI) in both HFrEF and heart failure with preserved ejection fraction (HFpEF).
  • Identify amyloidosis in HFpEF and examine the role of targeted therapy.
  • Appraise the role of interventional therapy for mitral regurgitation and atrial fibrillation in HFrEF.

Target Audience

  • Physicians
  • Medical Students
  • Fellows
  • Residents

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC) Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Part II MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to Accreditation Council for Continuing Medical Education (ACCME) for the purpose of granting ABIM MOC credit.

Program Director

  1. Richard J. Hamill, M.D.

    Richard J. Hamill, M.D.

    Professor
    Baylor College of Medicine

Term of Approval

January 1, 2021 through January 31, 2023. Original release date: January 1, 2021.

Disclosure Policy

The Office of Continuing Medical Education (OCME) makes every effort to develop CME activities that are scientifically based, accurate, current, and objectively presented. In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial SupportSM, Baylor College of Medicine (BCM) has implemented a mechanism requiring everyone in a position to control the content of an educational activity (e.g., directors, planning committee members, contributors, peer reviewers) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships: 1) at the time of the activity or within 12 months prior; and 2) of their spouses/partners.

Baylor College of Medicine does not view the existence of interests or relationships with commercial entities as implying bias or decreasing the value of a presentation. It is up to the participants to determine whether the interests or relationships influence the presenter with regard to exposition or conclusions.

If at any time during this activity you feel that there has been commercial or promotional bias, please inform us by using the commercial bias comments box in the evaluation form. Please answer the questions about balance in the CME activity evaluation candidly.

Disclosures

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

Presenter

  1. Ajith P. Nair, MD, FACC, FAHA

    Ajith P. Nair, MD, FACC, FAHA

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Program Director

  1. Richard J. Hamill, M.D.

    Richard J. Hamill, M.D.

    Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Planning Committee Members

  1. Richard J. Hamill, M.D.

    Richard J. Hamill, M.D.

    Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Erica Lescinskas, M.D.

    Erica Lescinskas, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  3. Zaven Sargsayan, M.D.

    Zaven Sargsayan, M.D.

    Assistant Professor
    Baylor College of Medicine and Ben Taub Hospital

    Disclosure:

    Nothing to disclose.

  4. Chirayu Shah, M.D., M.Ed.

    Chirayu Shah, M.D., M.Ed.

    Associate Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  5. Stephanie Sherman, M.D.

    Stephanie Sherman, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  6. Jefferson Triozzi, M.D. Placeholder Image

    Jefferson Triozzi, M.D.

    Internal Medicine Resident
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

CME Credit Available

You may claim CME credit after watching this activity.

View the CME Information

Presenter:

  1. Ajith P. Nair, MD, FACC, FAHA

    Ajith P. Nair, MD, FACC, FAHA

    Assistant Professor Baylor College of Medicine